US stocks rose to fresh records on Friday, propelled by strong earnings from Intel and drugmaker AbbVie as well as a weaker dollar, putting the three main indexes on track for their best four-week rally since 2016.
Intel shot up 10.6 per cent after reporting record revenues in the final quarter of 2017 and forecasting stronger-than-expected sales this year.
Wynn Resorts plunged after The Wall Street Journal reported allegations of sexual assault and harassment by CEO Steve Wynn.
For the week, the Dow rose 2.08 percent, the S&P 500 gained 2.22 percent and the Nasdaq advanced 2.31 percent. France's CAC40 Index fell 0.3 percent, the UK's FTSE 100 index slid 0.4 percent, while Germany's DAX Index dropped 0.9 percent.
The S&P 500 posted 125 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 178 new highs and 22 new lows.
Bond prices fell. The yield on the 10-year Treasury rose to 2.66 percent.
Stock futures pared gains on Friday after data showed USA economic growth unexpectedly slowed in the fourth quarter.
Earnings news may continue to attract attention on Friday, with Intel (INTC), Starbucks (SBUX), E*Trade (ETFC), and Western Digital (WDC) among the companies releasing their quarterly results after the close of today's trading.
Canada's main stock index rose on Friday, led by shares in Bombardier, which closed up 15 per cent after it won an unexpected trade victory against US planemaker Boeing Co.
Apple Already Planning to Kill the iPhone X
The company says this newly designed LCD will allow the size of a smartphone device to be almost the same as the display size. Apple did not respond to a Fortune request for comment on how many iPhone X units it sold during the fourth quarter.
Buoyed by AbbVie, the S&P healthcare index gained 2.17 per cent, scored its best day since November 2016 and was the best performer among the 11 major S&P sectors.
The Dow Jones industrial average added 140 points, or 0.5 percent, to 26,392.
Shares of Intel, which hit their highest in nearly two decades following its quarterly results, boosted the USA stock market, helping investors shrug off weaker-than-expected US economic growth data.
In a weekly note on capital flows, Bank of America Merrill Lynch analysts said that 98 percent of global equity markets are now trading above 50- and 200-day moving averages, though the pace of the melt-up meant a correction was increasingly likely.
Drugmaker AbbVie rose 6.4 percent after its results also came in ahead of expectations.
The Standard & Poor's 500 index rose 9 points, or 0.3 percent, to 2,847.
The Russell 2000 is up 4.04 points, or 0.3 percent.
The Nasdaq is up 507.77 points, or 7.4 percent. The yield on the 10-year Treasury fell to 2.64 percent.